Your browser doesn't support javascript.
loading
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium.
Fortner, Renée T; Poole, Elizabeth M; Wentzensen, Nicolas A; Trabert, Britton; White, Emily; Arslan, Alan A; Patel, Alpa V; Setiawan, V Wendy; Visvanathan, Kala; Weiderpass, Elisabete; Adami, Hans-Olov; Black, Amanda; Bernstein, Leslie; Brinton, Louise A; Buring, Julie; Clendenen, Tess V; Fournier, Agnès; Fraser, Gary; Gapstur, Susan M; Gaudet, Mia M; Giles, Graham G; Gram, Inger T; Hartge, Patricia; Hoffman-Bolton, Judith; Idahl, Annika; Kaaks, Rudolf; Kirsh, Victoria A; Knutsen, Synnove; Koh, Woon-Puay; Lacey, James V; Lee, I-Min; Lundin, Eva; Merritt, Melissa A; Milne, Roger L; Onland-Moret, N Charlotte; Peters, Ulrike; Poynter, Jenny N; Rinaldi, Sabina; Robien, Kim; Rohan, Thomas; Sánchez, Maria-José; Schairer, Catherine; Schouten, Leo J; Tjonneland, Anne; Townsend, Mary K; Travis, Ruth C; Trichopoulou, Antonia; van den Brandt, Piet A; Vineis, Paolo; Wilkens, Lynne.
Afiliación
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Poole EM; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Wentzensen NA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Washington, D.C.
  • Trabert B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Washington, D.C.
  • White E; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Arslan AA; New York University School of Medicine, New York, NY.
  • Patel AV; Epidemiology Research Program, American Cancer Society, Atlanta, GA.
  • Setiawan VW; University of Southern California, Los Angeles, CA.
  • Visvanathan K; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Weiderpass E; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Adami HO; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Black A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Bernstein L; Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Brinton LA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Buring J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Washington, D.C.
  • Clendenen TV; City of Hope, Duarte, CA.
  • Fournier A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Washington, D.C.
  • Fraser G; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Gapstur SM; Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Gaudet MM; New York University School of Medicine, New York, NY.
  • Giles GG; CESP "Health across Generations," INSERM, Univ Paris-Sud, UVSQ, Univ Paris-Saclay, Villejuif, France.
  • Gram IT; Gustave Roussy, Villejuif, France.
  • Hartge P; Loma Linda University, Loma Linda, CA.
  • Hoffman-Bolton J; Epidemiology Research Program, American Cancer Society, Atlanta, GA.
  • Idahl A; Epidemiology Research Program, American Cancer Society, Atlanta, GA.
  • Kaaks R; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Kirsh VA; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Knutsen S; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Koh WP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Washington, D.C.
  • Lacey JV; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Lee IM; Department of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
  • Lundin E; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
  • Merritt MA; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
  • Milne RL; Loma Linda University, Loma Linda, CA.
  • Onland-Moret NC; Health Services and Systems Research, Duke-NUS Medical School Singapore, Singapore.
  • Peters U; City of Hope, Duarte, CA.
  • Poynter JN; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA.
  • Rinaldi S; Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Robien K; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Rohan T; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI.
  • Sánchez MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, Norfolk Place, London, W2 1PG, United Kingdom.
  • Schairer C; Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Schouten LJ; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Tjonneland A; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Townsend MK; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Travis RC; Department of Pediatrics, University of Minnesota, Minneapolis, MN.
  • Trichopoulou A; International Agency for Research on Cancer, Lyon, France.
  • van den Brandt PA; Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, D.C.
  • Vineis P; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
  • Wilkens L; Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Int J Cancer ; 145(1): 58-69, 2019 07 01.
Article en En | MEDLINE | ID: mdl-30561796
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Epitelial de Ovario Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma Epitelial de Ovario Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos